Autobio Diagnostics Co Ltd
SSE:603658
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
38.18
66.36
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Autobio Diagnostics Co Ltd
Autobio Diagnostics Co Ltd
Intangible Assets
Autobio Diagnostics Co Ltd
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Intangible Assets
¥160.9m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Intangible Assets
¥1.4B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
|
Intangible Assets
¥253.8m
|
CAGR 3-Years
31%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
Winner Medical Co Ltd
SZSE:300888
|
Intangible Assets
¥995.2m
|
CAGR 3-Years
69%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Intangible Assets
¥169.5m
|
CAGR 3-Years
20%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Intco Medical Technology Co Ltd
SZSE:300677
|
Intangible Assets
¥564m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
Autobio Diagnostics Co Ltd
Glance View
Autobio Diagnostics Co., Ltd. engages in the research, development, manufacturing, integration, service, and distribution of in vitro diagnostic reagents and instruments. The company is headquartered in Zhengzhou, Henan and currently employs 5,031 full-time employees. The company went IPO on 2016-09-01. The firm's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The firm distributes its products in domestic markets.
See Also
What is Autobio Diagnostics Co Ltd's Intangible Assets?
Intangible Assets
160.9m
CNY
Based on the financial report for Jun 30, 2024, Autobio Diagnostics Co Ltd's Intangible Assets amounts to 160.9m CNY.
What is Autobio Diagnostics Co Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
-4%
Over the last year, the Intangible Assets growth was -15%. The average annual Intangible Assets growth rates for Autobio Diagnostics Co Ltd have been -12% over the past three years , -4% over the past five years .
You don't have any saved screeners yet
